Skip to content
★ Sign in to follow
PA

Peter A. Kiener

Board Director
Director
Cue Biopharma, Inc.Sucampo Pharmaceuticals, Inc.Medimmune Inc /DE
Total declarations
21
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€1.4M

Latest filing published 27 Mar 2023 for Cue Biopharma, Inc., €28k.

Filing timeline

BuySale
Peter A. Kiener

Insider track record

Disclosed buys
0
Disclosed sells
5
Signal history

Peter A. Kiener: trading record in brief

Peter A. Kiener is a declared insider at 3 companies (board member); the most frequent names are Sucampo Pharmaceuticals, Inc., Cue Biopharma, Inc. and Medimmune Inc /DE. In total, 21 filings cover trades dated from 8 February 2006 to 23 March 2023.

Sales make up the whole of the open-market record (5 sales, €1.4M). The rest of the record consists of 10 share grants and 5 option exercises. In 2023 alone, the filings show no purchases and 1 sale.

The record was last updated on 27 March 2023 with an open-market sale (€28k) in Cue Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Peter A. Kiener

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations